We are international
Donate
TEXT SIZE   


Dr. Jakubowiak - Lenalidomide, Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone In Newly Diagnosed Multiple Myeloma (MM): Final Results of Phase I/II MMRC Trial
Andrzej J Jakubowiak, MD, PhD
University of Michigan
Ann Arbor, Michigan
USA
12.02.10


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles